CLC number:
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2022-06-08
Cited: 0
Clicked: 1222
Yibin XIAO, Bo ZHANG, Yulian WU. Retraction Note to: Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis[J]. Journal of Zhejiang University Science B, 2022, 23(6): 528-528.
@article{title="Retraction Note to: Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis",
author="Yibin XIAO, Bo ZHANG, Yulian WU",
journal="Journal of Zhejiang University Science B",
volume="23",
number="6",
pages="528-528",
year="2022",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B17r0516"
}
%0 Journal Article
%T Retraction Note to: Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis
%A Yibin XIAO
%A Bo ZHANG
%A Yulian WU
%J Journal of Zhejiang University SCIENCE B
%V 23
%N 6
%P 528-528
%@ 1673-1581
%D 2022
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B17r0516
TY - JOUR
T1 - Retraction Note to: Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis
A1 - Yibin XIAO
A1 - Bo ZHANG
A1 - Yulian WU
J0 - Journal of Zhejiang University Science B
VL - 23
IS - 6
SP - 528
EP - 528
%@ 1673-1581
Y1 - 2022
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B17r0516
Abstract: The authors have retracted this article (
[1]XiaoYB, ZhangB, WuYL, 2018. Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 19(11):829-843.
Open peer comments: Debate/Discuss/Question/Opinion
<1>